SubHero Banner
Text

Myxredlin (insulin human in sodium chloride) – New drug approval

June 20, 2019 - The FDA approved Celerity Pharmaceuticals’ Myxredlin (insulin human in sodium chloride), to improve glycemic control in adults and pediatric patients with diabetes mellitus.

Download PDF